Hepatitis B virus infection in children: Epidemiology, natural course and prevention in Taiwan

Journal of the Formosan Medical Association

Volumn 95, Issue 8, 1996, Pages 593-598

  Chang, Mei Hwei ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

hepatitis B e antigen; hepatitis B surface antigen; hepatitis B vaccine; hepatitis B virus; pediatric hepatitis B infection; Taiwan

Indexed keywords

ALPHA INTERFERON; HEPATITIS B VACCINE;

CHILD; CHILDHOOD DISEASE; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; REVIEW; SEROCONVERSION; TAIWAN; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; CARRIER STATE; CAUSALITY; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; TAIWAN;

EID: 0029806651     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Jonas MM: Viral hepatitis. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, eds. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 2nd ed. St. Louis: Mosby Yearbook. 1996;1028-50.
2. Hsu HY, Chang MH, Chen DS, et al: Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before the mass hepatitis B virus vaccination program. In Taiwan. J Med Virol 1986;18:301-7.
3. Stevens CE, Beasley RP, Tsui J, et al: Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-4.
4. Hsu SC, Chang MH, NiYH, et al: Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr 1993;16:66-9.
5. Hsu HC, Lin YH, Chang MH, et al: Pathology of chronic hepatitis B virus infection in children with special reference to the intrahepatic expression of hepatitis B virus antigen. Hepatology 1988;8:378-82.
6. Chang MH, Chen DS, Hsu HC, et al: Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989;64:2377-80.
7. Chang MH, Lee CY, Chen DS, et al: Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 1987;111:34-9.
8. Alagille D: Acute and chronic viral hepatitis. In: Roy CC, Silverman A, Alagille D, eds. Pediatric Clinical Gastroenter ology. 14 ed. St. Louis: Mosby Yearbook, 1995;684-711.
9. Chang MH, Hsu HY, HSH HC, et al: The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis e antigen before three years of age. Hepatology 1995;22:1387-92.
10. Chang MH, Hwang LY, Hsu HC, et al: Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology 1988;8:374-7.
11. Chang MH, Sung JL, Lee CY, et al: Factors affecting the clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 1989;115:385-90.
12. Sung JL, Chen DS, Lai MY, et al: Epidemiological study on hepatitis B virus infection in Taiwan. Chinese J Gastroenterol 1984;1:1-9. [In Chinese]
13. Chen DS, Sung JL: Hepatitis B e antigen and its antibody in chronic type B hepatitis. J Gastroenterol Hepatol 1987;2:255-70.
14. Beasley RP, Hwang LY, Lin CC, et al: Incidence of hepatitis B virus infection in preschool children in Taiwan. J Infect Dis 1982;146:198-204.
15. Beasley RP, Hwang LY, Lin CC, et al: Incidence of hepatitis among students at a university in Taiwan. Amer J Epidemiol 1983;117:213-22.
16. Davies SV, Portmann BC, O'Grady JG, et al: Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991;13:150-7.
17. Hsu HY, Chang MH, Hsieh KH, et al: Cellular immune response to hepatitis B core antigen in maternal-infant transmission of hepatitis B virus. Hepatology 1992; 15:770-6.
18. Carman WF, Jacyna MR, Hadziyannis S, et al: Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B virus infection. Lancet 1989;2:588-91.
19. Omata M, Ehata T, Yokosuka O, et al: Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991;324:1699-704.
20. Laskus T, Parsing DH, Nowicki MJ, et al: Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993;105:1173-8.
21. Hsu HY, Chang MH, Lee CY, et al: Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. J Infect Dis 1995;171:776-81.
22. Ehata T, Omata M, Chuang WL, et al: Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993;91:1206-13.
23. Penna A, Chisari FV, Bertoletti A, et al: Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991;174:1565-70.
24. Maggiore G, Hadchonel M, Serra F, et al: A retrospective study of the role of delta agent infection in children with HBsAg positive chronic hepatitis. Hepatology 1985;5:7-9.
25. Hsu HY, Chang MH, Chen DS, et al: Hepatitis D virus infection in children with acute or chronic hepatitis B virus infection in Taiwan. J Pediatr 1988;112:888-92.
26. Beasley RP, Hwang LY, Lee CY, et al: Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-102.
27. Lee CY, Chang MH, Huang LM, et al: The protective efficacy of recombinant hepatitis B vaccine in infants of HBeAg positive HBsAg carrier mothers in Taiwan. Pediatr Infect Dis J 1991;10:299-303.
28. Lee GCY, Hwang LY, Beasley RP, et al: Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates. J Infect Dis 1983;148:526-9.
29. Tsen YJ, Chang MH, Hsu HY, et al: Seroepidemiology of hepatitis B virus infection in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991;34:96-9.
30. Chen DS, Hsu NH, Sung JL, et al: A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. J Am Med Assoc 1987;257:2597-603.
31. Cheng KF, Chang MH, Lee CY, et al: Response to supplementary vaccination with recombinant or plasma hepati tis B vaccine in healthy non-responding children. Vaccine 1994;12:899-902.
32. Tilzey AJ: Hepatitis B vaccine boosting: the debate continues. Lancet 1995;345:1000-1.
33. Lee PI, Lee CY, Huang LM, et al: Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr 1995;126:716-21.
34. Lee SD, Lo KJ, Wu JC, et al: Prevention of maternal-infant Hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology 1986;6:369-73.
35. Chang MH, Hsu HY, Li-Min Huang, et al: The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus. J Hepatol 1996;24:674-9.
36. Lin HH, Chang MH, Chen DS, et al: Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991;9:457-60.
37. Hoofnagle JH: α-Interferon therapy of chronic hepatitis B: current status and recommendations. J Hepatol 1990;11:S100-7.